Premier Biomedical

Premier Biomedical, Inc. is a research-based firm that develops cures for Amyotrophic Lateral Sclerosis (ALS), Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Clinical Depression, Alzheimer’s Disease, Blood Sepsis, Atherosclerosis, and Cancer. 

Type
Public
HQ
Jackson Center, US
Founded
2010
Premier Biomedical was founded in 2010 and is headquartered in Jackson Center, US

Premier Biomedical Office Locations

Premier Biomedical has an office in Jackson Center
Show all (1)

Premier Biomedical Financials and Metrics

Premier Biomedical Financials

USD

Revenue (Q3, 2017)

24.3 k

Gross profit (Q3, 2017)

13.2 k

Gross profit margin (Q3, 2017), %

54%

Net income (Q3, 2017)

3.7 m

Market capitalization (31-Oct-2017)

2.9 m

Closing share price (31-Oct-2017)

0

Cash (30-Sep-2017)

102.5 k
Premier Biomedical's current market capitalization is $2.9 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

R&D expense

217.4 k196.2 k234.1 k113.9 k

General and administrative expense

3 m223.4 k133.3 k191.4 k

Operating expense total

3.2 m419.6 k367.4 k305.2 k

Interest expense

400.4 k41.6 k198.9 k817.4 k
USDQ1, 2014Q2, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q3, 2017

Revenue

24.3 k

Cost of goods sold

11.1 k

Gross profit

13.2 k

Gross profit Margin, %

54%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

15.8 k102.6 k35.4 k22.4 k

Accounts Receivable

171.5 m

Current Assets

21.8 k115.5 k66.5 k33.9 k

PP&E

3.7 k5.1 k3.6 k5.1 k
USDQ1, 2014Q2, 2014Q3, 2017

Cash

113.6 k199.4 k102.5 k

Accounts Receivable

834

Inventories

108 k

Current Assets

119.1 k231.7 k218.8 k
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    (4.9 m)(1.4 m)(2.6 m)(1.8 m)

    Depreciation and Amortization

    7679541.5 k2.1 k

    Accounts Payable

    33.7 k25.2 k40.8 k32.5 k

    Cash From Operating Activities

    (428.2 k)(639.1 k)(462.2 k)(483.6 k)
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

    Net Income

    (307.3 k)(209.8 k)(936.6 k)(188.8 k)(415.1 k)(722.1 k)(435.1 k)

    Depreciation and Amortization

    233466

    Accounts Payable

    (104.6 k)(79.6 k)34.6 k209.5 k237.9 k299.4 k83.4 k143.7 k210.1 k

    Cash From Operating Activities

    (304.5 k)(418.6 k)
      Y, 2017

      Financial Leverage

      -0.1 x
      Show all financial metrics

      Premier Biomedical Market Value History

      Premier Biomedical's Web-traffic and Trends

      Premier Biomedical Online and Social Media Presence

      Premier Biomedical Company Life and Culture

      You may also be interested in